معرفی
Kert Mätlik is a neuroscientist specializing in molecular mechanisms of neurodegenerative diseases and stroke pathology. Affiliated with Tallinn University of Technology, he holds a Doctor's Degree from the University of Helsinki (2017) and a Master's Degree from Tallinn University of Technology (2005). His research focuses on neurotrophic factors, particularly MANF and CDNF proteins, and their therapeutic potential in neurological disorders.
Education:
- Doctor's Degree (2017), University of Helsinki, Institute of Biotechnology
- Master's Degree (2005), Tallinn University of Technology
Dr. Mätlik's research program investigates cell-type-specific responses in neurodegenerative conditions, with significant contributions to understanding Huntington's disease mechanisms and stroke recovery processes. His work employs advanced molecular techniques to profile specific neuronal populations in human brain tissue, revealing critical insights into selective neuronal vulnerability. Recent publications demonstrate his leadership in developing methodologies for isolating and analyzing nuclei from specific neuronal types in human cerebral cortex and striatum.
Analysis of his publication trends shows a consistent focus on translational neuroscience, bridging molecular mechanisms with potential therapeutic applications. His work spans neurodegenerative diseases, stroke pathology, and pain mechanisms, with increasing emphasis on human tissue studies in recent years.
Scientific Recognition:
- 2002 First Prize in National Student Research Competition
- Artur Linnu Scholarship in Gene Technology
Dr. Mätlik maintains active research collaborations across international institutions, contributing to our understanding of neurotrophic factor signaling and developing novel approaches for treating neurological disorders. His current work continues to advance the field of cell-type-specific analysis in neurodegenerative disease research.
